Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Residual Fatigue and Cognitive Deficits in Patients After Leucine-Rich Glioma-Inactivated 1 Antibody Encephalitis.

Binks SNM., Veldsman M., Easton A., Leite MI., Okai D., Husain M., Irani SR.

This study evaluates residual fatigue and cognitive defects in patients after leucine-rich glioma-inactivated 1 antibody encephalitis.

More information Original publication

DOI

10.1001/jamaneurol.2021.0477

Type

Journal article

Publication Date

2021-05-01T00:00:00+00:00

Volume

78

Pages

617 - 619

Total pages

2

Keywords

Antibodies, Autoantibodies, Cognition, Cognitive Dysfunction, Encephalitis, Fatigue, Glioma, Humans, Leucine